NASDAQ · Biotechnology
TECH (TECH) Stock
$72.29
+0.54%
NASDAQ: TECH
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
What to Expect From Bio-Techne's Next Quarterly Earnings Report
Barchart · Jul 20, 2026
Q1 Earnings Outperformers: Bio-Techne (NASDAQ:TECH) And The Rest Of The Research Tools & Consumables Stocks
StockStory · Jul 16, 2026
RBC Capital Downgrades Bio-Techne to Sector Perform From Outperform, Adjusts Price Target to $73 From $62
MT Newswires · Jul 9, 2026
Bio-Techne Expands AI-Engineered Designer Protein Portfolio
MT Newswires · Jul 8, 2026
Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
PR Newswire · Jul 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held0.31%
Institutions Held118.15%
Institutions Float Held118.51%
Peer Comparison
About TECH
TECH is led by CEO Kim Kelderman, employs 3,100 people, headquartered in Minneapolis, US, publicly traded since 1989.
TECH stock trades at $72.29 with a market capitalization of $11.32B. The stock is valued at a price-to-earnings (P/E) ratio of 67.74, price-to-book of 3.68, price-to-sales of 6.13. Over the past 52 weeks the stock has ranged between $43.20 and $72.29, and currently trades at its 52-week high. It pays a dividend yielding 0.67%.
On profitability, TECH generates a return on equity (ROE) of 5.34%, return on capital employed of 5.32%, an operating margin of 12.70%, a net profit margin of 9.05%.